# Efficacy and Safety Comparison of IVR and IVC Before Vitrectomy in Proliferative Diabetic Retinopathy

> **NCT05414149** · NA · COMPLETED · sponsor: **Peking University People's Hospital** · enrollment: 80 (actual)

## Conditions studied

- Proliferative Diabetic Retinopathy

## Interventions

- **PROCEDURE:** preoperative intravitreal injections of ranibizumab or conbercept

## Key facts

- **NCT ID:** NCT05414149
- **Lead sponsor:** Peking University People's Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-09-01
- **Primary completion:** 2022-05-31
- **Final completion:** 2022-05-31
- **Target enrollment:** 80 (ACTUAL)
- **Last updated:** 2022-06-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05414149

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05414149, "Efficacy and Safety Comparison of IVR and IVC Before Vitrectomy in Proliferative Diabetic Retinopathy". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT05414149. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*